[11c]cppc
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2021 (NCT04749433)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Macrophage colony stimulating factor receptorRadiopharmaceutical
CSF1R radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06223971 | Early Phase 1 (Phase 1) | Aug 6, 2024 | Johns Hopkins University, Radiological Society of North America |
| NCT05602142 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2023 | Department of Defense, Johns Hopkins University |
| NCT04749433 | Phase 1 | Sep 1, 2021 | Johns Hopkins University, Precision Molecular |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 3 | 3 | 2 | 2021 |
| Department of Defense | Government | 1 | 0 | 1 | 2023 |
| Precision Molecular | For profit | 1 | 0 | 1 | 2021 |
| Radiological Society of North America | Academic/Hospital | 1 | 0 | 1 | 2024 |
4 organizations
Page 1 / 1